Table 5.
Description of experimental groups
| Group | Treatment | Treatment abbreviation | |
Experimental design |
||
|---|---|---|---|---|---|---|
| Tumor | ZnPcS 4 -AN | Laser | Doxorubicin | |||
| 1 |
Filtered water and no tumor implantation (negative control) |
NC |
- |
- |
- |
- |
| 2 |
Tumor inoculation and no treatment (control tumor) |
CT |
+ |
- |
- |
- |
| 3 |
Intratumoral injection of 20 μL (0.5 mM) ZnPcS4-AN |
ZnPc |
+ |
+ |
- |
- |
| 4 |
Tumor irradiated only with light from a laser setup working at 670 nm, in a total dose of 100 J/cm2 |
LS |
+ |
- |
+ |
- |
| 5 |
Intratumoral injection of 0.5 mM ZnPcS4-AN followed by light activation considering the same treatment as described for group 4 |
PDT |
+ |
+ |
+ |
- |
| 6 |
Intratumoral injection of 20 mg/m2 doxorubicin |
Dox |
+ |
- |
- |
+ |
| 7 |
Intratumoral injection of 0.5 mM ZnPcS4-AN and 20 mg/m2 Dox |
ZnPc/Dox |
+ |
+ |
- |
+ |
| 8 |
Intratumoral injection of 20 mg/m2 Dox and the same treatment as group 4 |
Dox/LS |
+ |
- |
+ |
+ |
| 9 | Intratumoral injection of 0.5 mM ZnPcS4-AN and 20 mg/m2 Dox and the same treatment as group 5 | Dox/PDT | + | + | + | + |